Evaluating the cost-benefit profile of CPI stem cell therapy necessitates a comprehensive approach. Proponents often stress the possibility for meaningful therapeutic outcomes, principally in diseases where conventional treatments have proven inadequate. However, crucially important to consider the considerable financial investment associated with